Introduction Chronic obstructive pulmonary disease (COPD) is a chronic progressive condition with high symptom-burden, accounting for one death every 20 minutes in England and Wales. Patient-centred ...

Similarly, local pulmonary rehabilitation (PR) groups wrote to COPD patients on their database. Study team members gave educational talks to local PR and patient support groups, and at the end ...

Conclusion COPD patients commonly present acutely with ECOPD ... supported by joint working, education and electronic prescribing can improve staff knowledge and patient management.

Guidelines for its administration have for many years also cautioned its use with patients with chronic obstructive pulmonary disease (COPD). 1 Successive guidelines and prehospital textbooks have ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Terry Coker, COPD Patient I have been trying to make the best out of it since. I have no regrets. I have a good quality of life, I do just about anything I want to do. Narrator Terry's blocked ...

Several features of COPD (dyspnea, air hunger, functional decline, and the possibility of mechanical ventilation) commonly force patients and physicians to confront end-of-life issues. Chronic ...

COPD comprises several conditions ... These results highlight the importance of regular therapeutic education, assessing the ...

We hereby present a unique case of Achromobacter xylosoxidans denitrificans pneumonia in an immunocompetent patient with advanced chronic obstructive pulmonary disease (COPD). Our patient is a ...

At high altitudes, the reduced oxygen levels trigger physiological changes, but their impact on COPD patients remains uncertain. Researchers analysed data from a multicenter cohort study ...

The commentary discusses the COPD Foundation's PIVOT (Patient-Inspired Validation of Outcome Tools) initiative, a patient-centric framework to validate outcome measures for use in clinical trials ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).